Asosiy kontentga oʻtish
Maqola

Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain

Marian DiFigliaM. DiFiglia, E. Sapp, J. P. Vonsattel, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USAEllen SappK. O. Chase, N. Aronin, Departments of Medicine and Cell Biology, University of Massachusetts Medical Center, Worcester, MA 01655, USAKathryn ChaseM. DiFiglia, E. Sapp, J. P. Vonsattel, Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USAStephen W. DaviesK. O. Chase, N. Aronin, Departments of Medicine and Cell Biology, University of Massachusetts Medical Center, Worcester, MA 01655, USAGillian P. BatesS. W. Davies, Department of Anatomy and Developmental Biology, University College London, Gower Street, London WC1E, 6BT, UKJ.-P. G. VonsattelS. W. Davies, Department of Anatomy and Developmental Biology, University College London, Gower Street, London WC1E, 6BT, UKNeil AroninG. P. Bates, Division of Medical and Molecular Genetics, UMDS Guy's Hospital, London SE1 7E H, UK
1997en

Ochiq kirish: yoʻq

ABI

Annotatsiya

The cause of neurodegeneration in Huntington's disease (HD) is unknown. Patients with HD have an expanded NH2-terminal polyglutamine region in huntingtin. An NH2-terminal fragment of mutant huntingtin was localized to neuronal intranuclear inclusions (NIIs) and dystrophic neurites (DNs) in the HD cortex and striatum, which are affected in HD, and polyglutamine length influenced the extent of huntingtin accumulation in these structures. Ubiquitin was also found in NIIs and DNs, which suggests that abnormal huntingtin is targeted for proteolysis but is resistant to removal. The aggregation of mutant huntingtin may be part of the pathogenic mechanism in HD.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba